227. Osler disease Clinical trials / Disease details


Clinical trials : 54 Drugs : 73 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00588146
(ClinicalTrials.gov)
January 200726/12/2007Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaPhase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaAnemia;Liver Disease;HypoxemiaDrug: Pegylated Interferon Alpha2b;Other: Standard careMayo ClinicAugusta University;St. Michael's Hospital, Toronto;Schering-PloughTerminated18 Years70 YearsAll10Phase 2United States